Clinical trials

Assessing Long-Term Outcomes of Dupixent Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyposis (AROMA)

To characterize real-world utilization of DUPIXENT® for patients with CRSwNP.

Pediatric Allergy & Immunology Cohen Children’s Medical Center of NY | 865 Northern Blvd. | Great Neck | NY 11021

A randomised, double-blind, parallel group Phase III study to assess the efficacy and safety of 100 mg SC depemokimab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) – ANCHOR-1 (depemokimAb iN CHrOnic Rhinosinusitis)

This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).

Pediatric Allergy & Immunology Cohen Children’s Medical Center of NY | 865 Northern Blvd. | Great Neck | NY 11021

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lirentelimab in Adult Subjects with H-1 Antihistamine Refractory Chronic Spontaneous Urticaria

This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of subcutaneous lirentelimab (AK002) in adult subjects with H-1 antihistamine refractory chronic spontaneous urticaria...

Pediatric Allergy & Immunology Cohen Children’s Medical Center of NY | 865 Northern Blvd. | Great Neck | NY 11021

A phase I open-label trial to assess the tolerability and safety of an up-dosing regimen with once-daily peanut SLIT-tablet in adults, adolescents, and children with peanut allergy

This is a phase I, open-label, dose-escalation, multi-site trial including subjects with peanut allergy. Peanut SLIT tablets administered as 9 doses, In part 1, subjects will receive a peanut SLIT-tablet with one of five increasing doses once daily for 2 weeks...

Pediatric Allergy & Immunology Cohen Children’s Medical Center of NY | 865 Northern Blvd. | Great Neck | NY 11021

A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of Epicutaneous Immunotherapy with DBV712 250 µg in 4-7 year old Children with Peanut Allergy (VITESSE)

This study assessed the safety and effectiveness of a once-daily peanut patch placed on the skin for 12 months to induce desensitization in children 4-7 years old...

Pediatric Allergy & Immunology Cohen Children’s Medical Center of NY | 865 Northern Blvd. | Great Neck | NY 11021

A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess the Efficacy and Safety of Daily OM-85 Treatment vs. Placebo given in Children Aged 6 Months to 5 Years with Recurrent Wheezing

This study will assess the effectiveness and safety of daily OM-85 treatment in children 6 months to 5 years with recurrent wheezing. The treatment is known as the common name, Broncho-Vaxom in other countries...

Pediatric Allergy & Immunology Cohen Children’s Medical Center of NY | 865 Northern Blvd. | Great Neck | NY 11021

Clinical trials : allergy-immunology

Employees